Clinical trial
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
NCT07850284 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 25, 2026
- Completion date
- August 25, 2028
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
al amyloidosis, multiple myeloma